Cargando…
Belimumab Decreases Autophagy and Citrullination in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus
Belimumab (BLM) is a B lymphocyte stimulator (BLyS) inhibitor approved for the treatment of systemic lupus erythematosus (SLE). Autophagy is a cell survival mechanism involved in the pathogenesis of SLE. Citrullination is a post-translational modification catalyzed by peptidylarginine deiminase (PAD...
Autores principales: | Colasanti, Tania, Spinelli, Francesca Romana, Barbati, Cristiana, Ceccarelli, Fulvia, Scarpa, Susanna, Vomero, Marta, Alessandri, Cristiano, Valesini, Guido, Conti, Fabrizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773843/ https://www.ncbi.nlm.nih.gov/pubmed/35053379 http://dx.doi.org/10.3390/cells11020262 |
Ejemplares similares
-
B lymphocyte stimulator modulates number and function of endothelial progenitor cells in systemic lupus erythematosus
por: Spinelli, Francesca Romana, et al.
Publicado: (2019) -
The role of dietary sodium intake on the modulation of T helper 17 cells and regulatory T cells in patients with rheumatoid arthritis and systemic lupus erythematosus
por: Scrivo, Rossana, et al.
Publicado: (2017) -
Low expression of estrogen receptor β in T lymphocytes and high serum levels of anti-estrogen receptor α antibodies impact disease activity in female patients with systemic lupus erythematosus
por: Maselli, Angela, et al.
Publicado: (2016) -
Autophagy and Rheumatoid Arthritis: Current Knowledges and Future Perspectives
por: Vomero, Marta, et al.
Publicado: (2018) -
Anti-carbamylated protein antibodies as a new biomarker of erosive joint damage in systemic lupus erythematosus
por: Ceccarelli, Fulvia, et al.
Publicado: (2018)